|
NAE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.178000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.779000E-01 |
| Normal-vs-Stage2 |
8.529200E-01 |
| Normal-vs-Stage3 |
3.083800E-01 |
| Normal-vs-Stage4 |
7.494400E-01 |
| Stage1-vs-Stage2 |
8.265400E-01 |
| Stage1-vs-Stage3 |
2.203200E-01 |
| Stage1-vs-Stage4 |
7.095000E-01 |
| Stage2-vs-Stage3 |
3.816400E-01 |
| Stage2-vs-Stage4 |
6.859600E-01 |
| Stage3-vs-Stage4 |
5.091400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.207600E-01 |
| Normal-vs-AfricanAmerican |
7.230800E-01 |
| Normal-vs-Asian |
3.562200E-01 |
| Caucasian-vs-AfricanAmerican |
9.005600E-01 |
| Caucasian-vs-Asian |
5.083200E-01 |
| AfricanAmerican-vs-Asian |
5.361600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.590800E-01 |
| Normal-vs-Female |
5.213000E-01 |
| Male-vs-Female |
4.274200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.241400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.837200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.568600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.359200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.245600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.485390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.197000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.796400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.771600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.954200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.604800E-01 |
| Normal-vs-Grade 2 |
4.465200E-01 |
| Normal-vs-Grade 3 |
2.448400E-01 |
| Normal-vs-Grade 4 |
1.126220E-01 |
| Grade 1-vs-Grade 2 |
7.186600E-01 |
| Grade 1-vs-Grade 3 |
6.125800E-02 |
| Grade 1-vs-Grade 4 |
2.908100E-02 |
| Grade 2-vs-Grade 3 |
1.939650E-02 |
| Grade 2-vs-Grade 4 |
1.357920E-02 |
| Grade 3-vs-Grade 4 |
3.963800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.179600E-01 |
| Normal-vs-ccB subtype |
1.636840E-01 |
| ccA subtype-vs-ccB subtype |
1.759990E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.229800E-01 |
| Normal-vs-N1 |
2.165600E-01 |
| N0-vs-N1 |
2.667400E-01 |
|
|
